Visa defeats lawsuit over ‘card draining' Vanilla gift card scam
The Visa logo is seen on a card in this file photo. (Primakov / Shutterstock.com)
NEW YORK — Visa defeated a proposed class action lawsuit on Monday by consumers who accused the world's largest card payments network of failing to warn that its prepaid 'Vanilla' gift cards were susceptible to being drained by thieves.
U.S. District Judge Gregory Woods in Manhattan said it was unreasonable for consumers to consider gift cards impervious to scams, or that Visa's logo amounted to a promise that no scams would occur and the company would help victims.
Woods also rejected a claim that Visa provided inadequate warnings on the cards' packaging about possible tampering, citing news coverage of 'card draining' and comments in online forums about Visa Vanilla scams.
'No reasonable consumer would expect the allegedly 'widespread' practice of third-party scams affecting prepaid cards to somehow not affect one of the industry's major suppliers,' the judge wrote.
The lead plaintiff, Ira Schuman, of Scarsdale, New York, sued Visa and two Vanilla card issuers in January 2024, after learning that eight US$500 cards he bought as holiday gifts for employees in 2022 and 2023 had been emptied.
He said non-reloadable Vanilla cards sold at CVS, Target, Walgreens and other retailers came in thin cardboard sleeves that thieves could open and reseal, without being detected, after recording account information.
Lawyers for Schuman did not immediately respond to requests for comment. Visa, based in San Francisco, and its lawyers did not immediately respond to similar requests.
The lawsuit sought damages for purchasers of Visa-branded Vanilla cards in New York for alleged violations of the state's consumer protection laws.
(Reporting by Jonathan Stempel in New York; Editing by Leslie Adler)
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Toronto Sun
19 minutes ago
- Toronto Sun
Fixing problems with Phoenix payroll system cost taxpayers $5.1B: Official
Published Jun 23, 2025 • 2 minute read Federal seasonal worker Roxanne Merrill Young holds a sign during a Phoenix payroll system demonstration in Miramichi, N.B., in 2017. Photo by Jocelyn Turner / Postmedia Network OTTAWA — A top federal official said fixing the payroll problems caused by Phoenix cost taxpayers more than $5 billion — and they'll keep paying extra to run two public service payroll platforms at once as Ottawa weans itself off the problem-plagued system. This advertisement has not loaded yet, but your article continues below. THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY Subscribe now to read the latest news in your city and across Canada. Unlimited online access to articles from across Canada with one account. Get exclusive access to the Toronto Sun ePaper, an electronic replica of the print edition that you can share, download and comment on. Enjoy insights and behind-the-scenes analysis from our award-winning journalists. Support local journalists and the next generation of journalists. Daily puzzles including the New York Times Crossword. SUBSCRIBE TO UNLOCK MORE ARTICLES Subscribe now to read the latest news in your city and across Canada. Unlimited online access to articles from across Canada with one account. Get exclusive access to the Toronto Sun ePaper, an electronic replica of the print edition that you can share, download and comment on. Enjoy insights and behind-the-scenes analysis from our award-winning journalists. Support local journalists and the next generation of journalists. Daily puzzles including the New York Times Crossword. REGISTER / SIGN IN TO UNLOCK MORE ARTICLES Create an account or sign in to continue with your reading experience. Access articles from across Canada with one account. Share your thoughts and join the conversation in the comments. Enjoy additional articles per month. Get email updates from your favourite authors. THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK. Create an account or sign in to continue with your reading experience. Access articles from across Canada with one account Share your thoughts and join the conversation in the comments Enjoy additional articles per month Get email updates from your favourite authors Don't have an account? Create Account Alex Benay, associate deputy minister at Public Services and Procurement Canada, said the alternative to running the Phoenix system in tandem with its replacement, Dayforce, would have been worse. 'The unfortunate situation is there's no easy path,' he said. 'This is the one that's going to impact employees the least.' The other option, he said, would have been a more risky 'big bang' deployment that would have switched roughly 350,000 public servants from the old system to the new Dayforce system all at once. Read More That's what happened when the federal government introduced Phoenix, which led to nearly a decade of public service payroll errors and major lawsuits. Your noon-hour look at what's happening in Toronto and beyond. By signing up you consent to receive the above newsletter from Postmedia Network Inc. Please try again This advertisement has not loaded yet, but your article continues below. 'My commitment when I started this role was that I would not support that, for all the obvious reasons of where we are today, nine years later,' Benay said. He added that the 'deputy minister community' and ministers decided they 'do not want to do another big bang.' Benay said taxpayers likely spent about $5.1 billion to process the backlog of Phoenix errors that caused some public servants to be paid incorrectly — or sometimes not paid at all. On June 11, Ottawa announced it had awarded a 10-year contract to Dayforce worth $350.6 million which includes a possible extension to 20 years. 'This is not another Phoenix. The work is being done at small scale and transparently,' Benay said. 'We're hoping that this is a smarter, more human-centred transformation that'll be built to last.' This advertisement has not loaded yet, but your article continues below. Parallel testing of the new payroll system will start next year and the first two departments to adopt the new system will be Shared Services Canada and Public Services Procurement Canada. The initial amount spent to create Phoenix was $309 million, according to departmental spokesperson Jullian Paquin. Phoenix's origins date to 2009. It was originally designed to decrease the cost of processing the federal government's massive payroll. But the project failed on launch after being rolled out with no project oversight, according to a federal audit. The original price tag provided by IBM to implement Phoenix in 2012 was $274 million. — With files from Catherine Morrison. Toronto & GTA Toronto Maple Leafs Toronto Blue Jays World Other Sports
Globe and Mail
28 minutes ago
- Globe and Mail
Serina Therapeutics to Present at FORCE Family Office Investor Webinar on June 26, 2025
How Parkinson's affects million – and why current treatments are not enough Continuous dopaminergic stimulation (CDS): a next-gen approach to Parkinson's care Serina's drug candidate SER-252 is designed to deliver continuous symptom relief Join Serina CEO Steve Ledger for this live event hosted by FORCE Family Office HUNTSVILLE, AL, June 23, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. ('Serina') (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform ™ drug optimization technology, is pleased to announce that Chief Executive Officer Steve Ledger will present at an upcoming FORCE Family Office investor webinar titled "New Drug Optimization Platform to Transform Parkinson's Care.' The Event is scheduled to take place on Thursday, June 26, 2025, at 12:00 p.m. ET / 9:00 a.m. PT. In this presentation, Mr. Ledger will discuss how advanced Parkinson's disease impacts millions of people worldwide by affecting their ability to move and maintain quality of life. He will highlight the limitations of current medications, which often wear off quickly or cause unwanted side effects like tremors or stiffness. SER-252 is Serina's propriety polymer conjugate of apomorphine, a clinically proven dopamine agonist, which is designed to deliver continuous dopaminergic stimulation (CDS), which aims to provide smoother, longer-lasting symptom control and greater convenience. The discussion will also explore the unique advantages of Serina's POZ Platform ™, a next-generation drug optimization system with the potential to improve the safety, duration, and tolerability of Parkinson's treatments and other therapeutics. The webinar will be hosted by FORCE Family Office CEO, Steve Saltzstein, and include a Q&A session. Attendees may submit questions via the online chat feature during the event. To register for the complimentary event, please visit: About Serina Therapeutics Serina is a clinical-stage biotechnology company developing a pipeline of wholly owned drug product candidates to treat neurological diseases and other indications. Serina's POZ Platform ™ provides the potential to improve the integrated efficacy and safety profile of multiple modalities including small molecules, RNA-based therapeutics, and antibody-based drug conjugates (ADCs). Serina is headquartered in Huntsville, Alabama on the campus of the HudsonAlpha Institute of Biotechnology. For more information, please visit About FORCE Family Office FORCE is the largest network of Family Offices, Foundations, Endowments, and individual accredited investors in the United States. They introduce members of their network to leaders of public companies and privately held businesses at the capital acquisition stage. In addition, they facilitate co-investment opportunities, information sharing, philanthropy, and networking among their elite, peer-to-peer community. More information can be found at Cautionary Statement Regarding Forward-Looking Statement This release contains forward-looking statements within the meaning of federal securities laws. These statements are based on management's current expectations, plans, beliefs, or forecasts for the future, and are subject to uncertainty and changes in circumstances. Any express or implied statements in this press release that are not statements of historical fact, including statements about the potential of Serina's POZ polymer technology, are forward-looking statements that involve substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Risks and uncertainties include, among other things, the uncertainties inherent in research and development, including the ability to meet anticipated clinical endpoints, commencement and/or completion dates for clinical trials, regulatory submission dates, regulatory approval dates and/or launch dates, as well as the possibility of unfavorable new clinical data and further analyses of existing clinical data; the risk that clinical trial data are subject to differing interpretations and assessments by regulatory authorities; whether regulatory authorities will be satisfied with the design of and results from our clinical studies; whether and when any applications may be filed for any drug or vaccine candidates in any jurisdictions; whether and when regulatory authorities may approve any potential applications that may be filed for any drug or vaccine candidates in any jurisdictions, which will depend on a myriad of factors, including making a determination as to whether the product's benefits outweigh its known risks and determination of the product's efficacy and, if approved, whether any such drug or vaccine candidates will be commercially successful; decisions by regulatory authorities impacting labeling, manufacturing processes, safety and/or other matters that could affect the availability or commercial potential of any drug or vaccine candidates; and competitive developments. These risks as well as other risks are more fully discussed in Serina's Annual Report on Form 10-K, and Serina's other periodic reports and documents filed from time to time with the SEC. The information contained in this release is as of the date hereof, and Serina assumes no obligation to update forward-looking statements contained in this release as the result of new information or future events or developments. The information contained in this release is as of the date hereof, and Serina assumes no obligation to update forward-looking statements contained in this release as the result of new information or future events or developments.
CTV News
28 minutes ago
- CTV News
Jury orders man to pay US$500K for assaulting police officer who killed himself after U.S. Capitol riot
This image from the Department of Justice statement of facts to support an arrest warrant for David Walls-Kaufman, shows an image from police body-worn video, contained and annotated by the source, of David Walls-Kaufman in the U.S. Capitol Jan. 6, 2021, in Washington. (Department of Justice via AP) WASHINGTON — A federal jury on Monday awarded $500,000 to the widow and estate of a police officer who killed himself nine days after he helped defend the U.S. Capitol from a mob of rioters, including a man who scuffled with the officer during the attack. The eight-member jury ordered that man, 69-year-old chiropractor David Walls-Kaufman, to pay $380,000 in punitive damages and $60,000 in compensatory damages to Erin Smith for assaulting her husband, Metropolitan Police Officer Jeffrey Smith, inside the Capitol on Jan. 6, 2021. They awarded an additional $60,000 to compensate Jeffrey Smith's estate for his pain and suffering. The judge presiding over the civil trial dismissed Erin Smith's wrongful-death claim against Walls-Kaufman before jurors began deliberating last week. U.S. District Judge Ana Reyes said no reasonable juror could conclude that Walls-Kaufman's actions were capable of causing a traumatic brain injury leading to Smith's death. Walls-Kaufman, who lived a few blocks from the Capitol, denied assaulting Smith. He says any injuries that the officer suffered on Jan. 6 occurred later in the day, when another rioter threw a pole that struck Smith around his head. On Friday, the jury sided with Erin Smith and held Walls-Kaufman liable for assaulting her 35-year-old husband — an encounter captured on the officer's body camera. 'Erin is grateful to receive some measure of justice,' said David P. Weber, one of her attorneys. Walls-Kaufman said the outcome of the trial is 'absolutely ridiculous.' 'No crime happened. I never struck the officer. I never intended to strike the officer,' he said. 'I'm just stunned.' After the jury left the courtroom, Reyes encouraged the parties to confer and discuss a possible settlement to avoid the time and expense of an appeal and for the sake of 'finality.' 'You guys settle, you can move on with your lives,' the judge said. Walls-Kaufman's attorney, Hughie Hunt, described the jury's award as 'shocking.' 'We're talking about a three-second event,' he told the judge. 'It's not shocking, Mr. Hunt. A lot of things can happen in three seconds,' Reyes replied. Jeffrey Smith was driving to work for the first time after the Capitol riot when he shot and killed himself with his service weapon. His family said he had no history of mental health problems before the Jan. 6 riot. Erin Smith claims Walls-Kaufman struck her husband in the head with his own police baton, giving him a concussion and causing psychological and physical trauma that led to his suicide. The police department medically evaluated Smith and cleared him to return to full duty before he killed himself. In 2022, the District of Columbia Police and Firefighters' Retirement and Relief Board determined that Smith was injured in the line of duty and the injury was the 'sole and direct cause of his death,' according to the lawsuit. Walls-Kaufman served a 60-day prison sentence after pleading guilty to a Capitol riot-related misdemeanor in January 2023, but he was pardoned in January. On his first day back in the White House, President Donald Trump pardoned, commuted prison sentences or ordered the dismissal of cases for all of the nearly 1,600 people charged in the attack. More than 100 law-enforcement officers were injured during the riot. Capitol Police Officer Brian Sicknick collapsed and died a day after engaging with the rioters. A medical examiner later determined he suffered a stroke and died of natural causes. Howard Liebengood, a Capitol police officer who responded to the riot, also died by suicide after the attack. Erin Smith's quest isn't over. She applied for the National Law Enforcement Memorial to add her husband's name as a line-of-duty death. Weber said they're hoping for a decision soon. Michael Kunzelman, The Associated Press
